Wells Fargo’s Apollo Endosurgery, Inc. APEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-236
| Closed | -$2.34K | – | 7809 |
|
|
2023
Q1 | $2.34K | Sell |
236
-28
| -11% | -$277 | ﹤0.01% | 6202 |
|
|
2022
Q4 | $2.63K | Buy |
264
+12
| +5% | +$89 | ﹤0.01% | 5941 |
|
|
2022
Q3 | $1K | Buy |
252
+42
| +20% | +$233 | ﹤0.01% | 6552 |
|
|
2022
Q2 | $1K | Buy |
210
+20
| +11% | +$95 | ﹤0.01% | 6695 |
|
|
2022
Q1 | $1K | Buy |
190
+6
| +3% | +$37 | ﹤0.01% | 6920 |
|
|
2021
Q4 | $2K | Buy |
184
+60
| +48% | +$524 | ﹤0.01% | 6938 |
|
|
2021
Q3 | $1K | Buy |
124
+38
| +44% | +$327 | ﹤0.01% | 6866 |
|
|
2021
Q2 | $1K | Buy |
86
+2
| +2% | +$14 | ﹤0.01% | 6799 |
|
|
2021
Q1 | $0 | Hold |
84
| – | – | ﹤0.01% | 7618 |
|
|
2020
Q4 | $0 | Buy |
84
+19
| +29% | +$50 | ﹤0.01% | 7261 |
|
|
2020
Q3 | $0 | Sell |
65
-18
| -22% | -$27 | ﹤0.01% | 7147 |
|
|
2020
Q2 | $0 | Hold |
83
| – | – | ﹤0.01% | 7040 |
|
|
2020
Q1 | $0 | Buy |
83
+80
| +2,667% | +$210 | ﹤0.01% | 7043 |
|
|
2019
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 6865 |
|
|
2019
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 6851 |
|
|
2019
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 6715 |
|
|
2019
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 6583 |
|
|
2018
Q4 | $0 | Sell |
3
-400
| -99% | -$1.98K | ﹤0.01% | 6692 |
|
|
2018
Q3 | $3K | Buy |
403
+400
| +13,333% | +$3.11K | ﹤0.01% | 6202 |
|
|
2018
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 6663 |
|
|
2018
Q1 | $0 | Sell |
3
-997
| -100% | -$6.28K | ﹤0.01% | 6643 |
|
|
2017
Q4 | $6K | Sell |
1,000
-1,000
| -50% | -$4.55K | ﹤0.01% | 6030 |
|
|
2017
Q3 | $9K | Buy |
+2,000
| New | +$10.6K | ﹤0.01% | 5905 |
|
|
2017
Q1 | – | Sell |
-1
| Closed | – | – | 6588 |
|
|
2016
Q4 | $0 | Buy |
+1
| New | +$15 | ﹤0.01% | 6514 |
|
Wells Fargo's APEN Position: Q2 2023 in Review
Wells Fargo sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 236 shares — an estimated $2.34K sold.
Wells Fargo first reported a position in APEN in Q4 2016 and held it in 24 quarters. The position peaked at $9K in Q3 2017. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.
- Wells Fargo reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
- Wells Fargo sold 236 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $2.34K.
- Wells Fargo first reported a position in Apollo Endosurgery, Inc. in Q4 2016 and held it in 24 quarters.
- Wells Fargo's Apollo Endosurgery, Inc. position peaked at $9K in Q3 2017.
- 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.
Based on Wells Fargo's 13F filing for Q2 2023, filed 15 Aug 2023.